Blincyto
Infusion
registration number
54/26/0736
What Blincyto contains
blinatumomab.
other ingredients
Powder:
Citric acid monohydrate
Trehalose dihydrate
Lysine hydrochloride
Polysorbate 80
Sodium hydroxide
IV solution stabiliser:
Citric acid monohydrate
Lysine hydrochloride
Polysorbate 80
Sodium hydroxide
Water for injection.
Therapeutic classification
Antineoplastic agents (L01) L01FX.